Boston University Medical Campus, Department of Medicine, Section of Gastroenterology, School of Medicine, Suite 504, 650 Albany Street, Boston, Massachusetts 02118, USA.
J Biomed Opt. 2011 Jun;16(6):067009. doi: 10.1117/1.3592488.
Optical spectroscopy has shown potential as a real-time, in vivo, diagnostic tool for identifying neoplasia during endoscopy. We present the development of a diagnostic algorithm to classify elastic-scattering spectroscopy (ESS) spectra as either neoplastic or non-neoplastic. The algorithm is based on pattern recognition methods, including ensemble classifiers, in which members of the ensemble are trained on different regions of the ESS spectrum, and misclassification-rejection, where the algorithm identifies and refrains from classifying samples that are at higher risk of being misclassified. These "rejected" samples can be reexamined by simply repositioning the probe to obtain additional optical readings or ultimately by sending the polyp for histopathological assessment, as per standard practice. Prospective validation using separate training and testing sets result in a baseline performance of sensitivity = .83, specificity = .79, using the standard framework of feature extraction (principal component analysis) followed by classification (with linear support vector machines). With the developed algorithm, performance improves to Se ∼ 0.90, Sp ∼ 0.90, at a cost of rejecting 20-33% of the samples. These results are on par with a panel of expert pathologists. For colonoscopic prevention of colorectal cancer, our system could reduce biopsy risk and cost, obviate retrieval of non-neoplastic polyps, decrease procedure time, and improve assessment of cancer risk.
光学光谱学已显示出作为内窥镜检查中识别肿瘤的实时、体内诊断工具的潜力。我们提出了一种诊断算法的开发,以将弹性散射光谱(ESS)谱分类为肿瘤或非肿瘤。该算法基于模式识别方法,包括集成分类器,其中集成的成员在 ESS 光谱的不同区域进行训练,以及错误分类拒绝,其中算法识别并避免对误分类风险较高的样本进行分类。这些“拒绝”的样本可以通过简单地重新定位探头以获得额外的光学读数,或者最终通过按照标准实践将息肉送去进行组织病理学评估来重新检查。使用单独的训练集和测试集进行前瞻性验证,在使用标准特征提取(主成分分析)框架进行分类(使用线性支持向量机)之后,基线性能的灵敏度为.83,特异性为.79。通过开发的算法,性能提高到 Se ∼ 0.90,Sp ∼ 0.90,但代价是拒绝 20-33%的样本。这些结果与一组专家病理学家相当。对于结肠镜预防结直肠癌,我们的系统可以降低活检风险和成本,避免非肿瘤性息肉的取回,减少手术时间,并提高癌症风险评估。